Mink Therapeutics Inc

CUSIP 603693102COMINKTQ4 2025

Mink Therapeutics Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

79.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

6 filings · latest May 22, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	May 22, 2024	Gkcc, LLC	13G	11.8%	4.64M	SEC
2	Feb 14, 2024	Armen Garo H	13D	9.7%	3.51M	SEC
3	May 26, 2023	Agenus Inc	13D/A	62.5%	21.52M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Horizon Financial Services, LLC	160	$1.8K